EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phagocytic activity of blood monocytes and neutrophils in moderate COVID-19 patients and impact of immune therapy with bacterial lysates

Mikhail Kostinov iD, Oksana Svitich, Alexander Chuchalin, Viliya Gajnitdinova, Irina Bisheva, Svetlana Skhodova, Valerij Osiptsov, Vitalij Tatevosov, Nadezhda Kryukova iD, Isabella Khrapunova, Alexander Cherdantsev, Irina Soloveva und 7 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0324987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Mikhail Kostinov und 18 weiteren Autor:innen. Beteiligte Einrichtung: I. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russian Federation. Hauptthemen laut MEDLINE: COVID-19, Phagocytosis, Monocytes, Neutrophils. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Monocytes, macrophages and dendritic cells are involved in phagocytic reactions, which potentially play an important role in the pathogenesis of COVID-19. Imbalance of these cells in peripheral blood has proven to affect not only innate but also adaptive immunity. It is possible that a search for strategies to restore monocyte activity could be a major step in achieving immune control over COVID-19. The aim of this study was to investigate the relationship between phagocytic activity of peripheral-blood monocytes and neutrophils, and COVID-19 severity, to assess the effects of a bacteria-based immunostimulating agent on phagocytosis parameters in in-hospital COVID-19 patients. Materials and methods The study included 105 adult patients with moderate COVID-19, who had been hospitalized in 2020–2021 and treated in accordance with the recommendations of the Ministry of Health of the Russian Federation. All patients were divided into two groups: in Group 1 patients received standard treatment and Immunovac VP4 therapeutic vaccine, a bacteria-based immunostimulating agent as add-on therapy from Day 1 of hospitalization; in Group 2 patients did not receive any add-on treatment. The study parameters included C-reactive protein (CRP), aspartate aminotransferase (AST), SpO 2 , lung involvement on chest computer tomography (CT) scan, and phagocytic activity of peripheral-blood leukocytes based on the absorption activity (AA) of monocytes and neutrophilic granulocytes against S. аureus) . The parameters were assessed at 1, 14 and 30 days.

Results

Based on a cluster analysis of the clinical findings and the results of diagnostic tests obtained on admission, the patients were divided into 2 clusters: cluster 1 including patients with a more severe disease (n = 34) and cluster 2 including patients with a less severe disease (n = 71). Cluster 1 patients had higher levels of CRP (20.1 vs . 2.2 mg/mL, p < 0.001), AST (32.9 vs . 26.2 U/L, p = 0.003), lower SpO 2 (94% vs . 96%, p < 0,001) and more extensive lung involvement on chest CT scan (35% vs . 12%, p < 0,001). There was a statistically significant direct correlation between blood monocyte AA and SpO 2 (p = 0.04), an inverse correlation between monocyte AA and CRP (p = 0.003) and the extent of lung involvement on CT scan (p = 0.05). In less severe COVID-19 patients (cluster 2), no statistically significant correlation was observed. In more severe COVID-19 patients (cluster 1), there was a rise in monocyte AA on day 30 of hospitalization both in the control group (from 86.6 to 92.2, p = 0.03) and the main group, who received Immunovac VP4 add-on therapy (from 87.3 to 98.3, p = 0.05). However, the patients who received the immunostimulating agent, had higher monocyte PI than the controls, without the immunostimulant (p = 0.05). Patients from cluster 1 who were given Immunovac VP4 had higher SpO 2 levels (98% vs . 97%, p = 0.01) than those who had received only the standard treatment.

Discussion

Blood monocyte AA correlates with COVID-19 severity: patients with less severe disease have higher AA and those with more severe illness have lower AA. The standard treatment, combined with Immunovac VP4 enhances phagocytic activity of peripheral-blood monocytes, which is associated with a more marked increase in SpO 2 , especially in more severe patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19PhagocytosisMonocytesNeutrophilsHumansMaleFemaleMiddle AgedSARS-CoV-2AgedAdultC-Reactive ProteinSeverity of Illness IndexImmunotherapyBacterial Lysates

Substanzen

C-Reactive ProteinBacterial Lysates

Autor:innen und Institutionen

  • I. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russian Federation.
  • I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
  • Pirogov Russian National Research Medical University, Moscow, Russian Federation.
  • The Main Military Clinical Hospital of the National Guard Troops, Moscow, Russian Federation.
  • Ulyanovsk State University, Ulyanovsk, Russian Federation.
  • Branch Campus of the Russian Medical Academy of Continuous Professional Education, Novokuznetsk State Institute for Advanced Training of Physicians, Novokuznetsk, Russian Federation.

ORCID-Profile: Mikhail Kostinov, Nadezhda Kryukova

Zitieren

APA

Kostinov, M., Svitich, O., Chuchalin, A., Gajnitdinova, V., Bisheva, I., Skhodova, S., Osiptsov, V., Tatevosov, V., Kryukova, N., Khrapunova, I., Cherdantsev, A., Soloveva, I., Akhmatova, N., Kurbatova, E., Polishchuk, V., Kostinova, A., Vlasenko, A., Loktionova, M., & Poddubikov, A. (2025). Phagocytic activity of blood monocytes and neutrophils in moderate COVID-19 patients and impact of immune therapy with bacterial lysates. PLOS One. https://doi.org/10.1371/journal.pone.0324987

Vancouver

Kostinov M, Svitich O, Chuchalin A, Gajnitdinova V, Bisheva I, Skhodova S, et al. Phagocytic activity of blood monocytes and neutrophils in moderate COVID-19 patients and impact of immune therapy with bacterial lysates. PLOS One. 2025. doi:10.1371/journal.pone.0324987

BibTeX
@article{Kostinov2025,
  author = {Kostinov, Mikhail and Svitich, Oksana and Chuchalin, Alexander and Gajnitdinova, Viliya and Bisheva, Irina and Skhodova, Svetlana and Osiptsov, Valerij and Tatevosov, Vitalij and Kryukova, Nadezhda and Khrapunova, Isabella and Cherdantsev, Alexander and Soloveva, Irina and Akhmatova, Nelli and Kurbatova, Ekaterina and Polishchuk, Valentina and Kostinova, Aristitsa and Vlasenko, Anna and Loktionova, Marina and Poddubikov, Arseniy},
  title = {Phagocytic activity of blood monocytes and neutrophils in moderate COVID-19 patients and impact of immune therapy with bacterial lysates},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0324987}
}
Kostenlos starten →